After a multi-year run, sentiment around Eli Lilly (NYSE: LLY ) and the broader sector has deteriorated. This has resulted in steep underperformance relative to the market, driven by the market waiting for more clarityI am currently studying economics and accounting at UCSB, and interning at a UBS wealth management office. I am seeking a career in equity research, and I became passionate about equities through managing a stock portfolio of companies that I track closely.Analyst’s Disclosure:I/we have a bene ...